News
PAHC
20.73
-1.29%
-0.27
Should You Retain Charles River Stock in Your Portfolio Now?
NASDAQ · 15h ago
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
NASDAQ · 16h ago
Henry Schein Stock to Gain From New Acquisitions Amid Macro Woes
Barchart · 17h ago
New Product Offerings Support QIAGEN's Shares Amid Currency Woes
NASDAQ · 12/30/2024 15:49
STERIS Gains From Expanded Product Offerings Amid Macro Issues
NASDAQ · 12/30/2024 15:27
Weekly Report: what happened at PAHC last week (1223-1227)?
Weekly Report · 12/30/2024 10:49
Should You Hold Align Technology Stock in Your Portfolio Right Now?
NASDAQ · 12/27/2024 10:58
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock
NASDAQ · 12/26/2024 14:51
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
NASDAQ · 12/26/2024 12:00
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga · 12/24/2024 13:16
Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?
NASDAQ · 12/24/2024 12:17
Align Shares Down on Macroeconomic Issues, ASP Challenges
NASDAQ · 12/23/2024 14:35
Should You Retain Teleflex Stock in Your Portfolio Right Now?
NASDAQ · 12/23/2024 14:29
Weekly Report: what happened at PAHC last week (1216-1220)?
Weekly Report · 12/23/2024 10:54
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs
Barchart · 12/23/2024 08:58
MYGN Stock Might Gain From the New Recognition of RiskScore Study
NASDAQ · 12/20/2024 12:53
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?
NASDAQ · 12/19/2024 12:27
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
NASDAQ · 12/19/2024 12:24
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
NASDAQ · 12/18/2024 12:48
Phibro Animal Health Price Target Raised to $25.00/Share From $20.00 by Morgan Stanley
Dow Jones · 12/17/2024 17:13
More
Webull provides a variety of real-time PAHC stock news. You can receive the latest news about Phibro Animal through multiple platforms. This information may help you make smarter investment decisions.
About PAHC
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.